Skip to main content

Milestone Pharmaceuticals Inc.

MIST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001408443

No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q3 2026, worth $43.6M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$46.2M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, 0 vs. previous quarter
73
13F valueReported value at the end of Q3 2026
$43.6M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$63.1M
No comparable prior period
Free cash flow, FY2025
-$49.3M
No comparable prior period
Revenue, Q3 FY2026
$2.96M
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
19.9M
Shares sold short
Change
+185.4K
+0.9% vs. previous
Days to cover
24.83
At average daily volume

Superinvestors holding MIST, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding MIST at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Milestone Pharmaceuticals Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 20, 2026 (view filing)Apr 164 daysOliveto JosephPresident and CEOSSale−36.5K$2.26−$82.5K−7.6%446.2K after10b5-1
Jan 28, 2026 (view filing)Dec 15, 2025-Jan 26, 202644 daysLateNelson Jeffrey EdwardChief Operating OfficerSSale−70.3K$2.25−$158.2K−58.5%49.8K after2 lots
Jan 28, 2026 (view filing)Dec 15, 2025-Jan 26, 202644 daysLateBharucha DavidChief Medical OfficerSSale−70.3K$2.25−$158.2K−38.3%113.2K after2 lots
Jan 28, 2026 (view filing)Dec 15, 2025-Jan 26, 202644 daysLateHasija AmitCFO & EVP of Corp. DevelopmentSSale−70.3K$2.25−$158.2K−41.3%99.8K after2 lots
Jan 28, 2026 (view filing)Dec 15, 2025-Jan 26, 202644 daysLateMuller LorenzChief Commercial OfficerSSale−64.7K$2.25−$145.9K−24.0%205.4K after2 lots
Jan 28, 2026 (view filing)Dec 15, 2025-Jan 26, 202644 daysLateOliveto JosephPresident and CEOSSale−167.6K$2.24−$375.3K−25.8%482.7K after2 lots
Jan 9, 2026 (view filing)Jan 7-82 daysOliveto JosephPresident and CEOSSale−43.5K$2.25−$97.9K−12.5%303.7K after2 lots10b5-1
Dec 5, 2022 (view filing)Dec 1-54 daysBharucha DavidChief Medical OfficerPPurchase+10.0K$4.74+$47.4KNew position10.0K after2 lots
Oct 21, 2022 (view filing)Oct 192 daysWills Robert JamesDirectorPPurchase+15.0K$4.93+$74.0KNew position15.0K after
Oct 21, 2022 (view filing)Oct 201 dayPasternak Richard CDirectorPPurchase+10.0K$5.20+$52.0KNew position10.0K after

Top 10 13F holders, Q3 2026

See all 73 holders

The largest institutional positions in Milestone Pharmaceuticals Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding MIST in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Propel Bio Management, LLC9,449,727$8.18M4.34%+2,020,137+27.2%Added
Pavaki Capital Management LLC9,337,848$8.08M4.04%+270,000+3.0%Added
RTW Investments, LP7,833,336$6.78M0.07%00.0%Unchanged
Point72 Asset Management, L.P.5,467,247$4.73M0.01%+56,109+1.0%Added
Simplify Asset Management Inc.3,349,379$2.90M0.05%00.0%Unchanged
Millennium Management LLC2,235,274$1.94M0.00%−906,945−28.9%Reduced
Two Sigma Investments, LP1,721,021$1.49M0.00%−318,994−15.6%Reduced
Kalehua Capital Management LLC1,651,258$1.43M1.08%+382,021+30.1%Added
RVW Wealth, LLC1,148,260$994.0K0.06%+1,148,260New
Marshall Wace, LLP1,117,642$972.4K0.00%−680,053−37.8%Reduced

Holders of 5% or more of MIST

See all 4 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Milestone Pharmaceuticals Inc..

Largest holders of MIST from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Propel Bio Management, LLC13G/A10.10%12.6M shares+0.20 ppfrom 9.90%Dec 23, 20252 filingsNov 20, 2026SEC
RTW Investments, LP13G/A9.90%12.4M shares0.00 ppfrom 9.90%Feb 12, 20216 filingsMay 15, 2026SEC
Pavaki Capital Management LLC13G7.30%9.07M sharesNewAug 7, 20261 filingAug 7, 2026SEC
Adage Capital Management, L.P.13G/A6.37%8.00M shares−3.62 ppfrom 9.99%Nov 13, 20252 filingsMay 13, 2026SEC